SNSE: Sensei Biotherapeutics, Inc. Stock

by  •  • Comments Off on SNSE: Sensei Biotherapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 11.11
Enterprise Value ($M) -8.02
Book Value ($M) 45.78
Book Value / Share 1.82
Price / Book 0.24
NCAV ($M) 40.62
NCAV / Share 1.62
Price / NCAV 0.27

Profitability (mra)
Return on Invested Capital (ROIC) -0.59
Return on Assets (ROA) -0.40
Return on Equity (ROE) -0.42

Liquidity (mrq)
Quick Ratio 8.84
Current Ratio 8.84

Balance Sheet (mrq) ($M)
Current Assets 48.10
Assets 53.25
Liabilities 7.47
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2024-03-07 13D/A Newtyn Management, LLC 4.95 -14.72

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 9,711 72,828 13.33
2025-03-06 4,872 13,479 36.15
2025-03-05 30,313 56,368 53.78
2025-03-04 24,065 88,558 27.17

(click for more detail)

Similar Companies
SNDL – SNDL Inc. SNGX – Soligenix, Inc.
SNPX – Synaptogenix, Inc. SNTI – Senti Biosciences, Inc.
SNYR – Synergy CHC Corp.


Financial data and stock pages provided by
Fintel.io